Manufacturer record
Laborate Pharmaceuticals India Ltd (Unit II) 31: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Laborate Pharmaceuticals India Ltd (Unit II) 31 (Haryana) were declared Not of Standard Quality between February 2025 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Laborate Pharmaceuticals India Ltd (Unit II) 31 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole & Domperidone Capsules | ORECA-004Mfg 2024-04 · Exp 2026-03 | Rabeprazole & Domperidone Capsules does not comply Rabeprazole sodium Assay as per STPAssay | DCL TelanganaState lab | Nov 2025 |
| Para 500 | NBRT- 018Mfg 2023-05 · Exp 2026-04 | The sample does not conforms to the IP 2022 requirement w.r.t dissolution testDissolution | DTL Srinagar (J&K)State lab | Feb 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.